StepUp Health ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Bankruptcy risk for industry  2.3% 2.3% 2.3% 2.3% 2.3%  
Bankruptcy risk  0.0% 0.0% 10.5% 5.5% 6.0%  
Credit score (0-100)  0 0 22 41 38  
Credit rating  N/A N/A BB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 282 940 -5.0  
EBITDA  0.0 0.0 -91.7 606 -10.6  
EBIT  0.0 0.0 -91.7 606 -10.6  
Pre-tax profit (PTP)  0.0 0.0 -91.9 603.1 -10.6  
Net earnings  0.0 0.0 -91.9 636.9 -10.6  
Pre-tax profit without non-rec. items  0.0 0.0 -91.9 603 -10.6  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 -51.9 585 574  
Interest-bearing liabilities  0.0 0.0 138 4.4 0.0  
Balance sheet total (assets)  0.0 0.0 95.3 611 574  

Net Debt  0.0 0.0 43.2 -51.0 -28.6  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 282 940 -5.0  
Gross profit growth  0.0% 0.0% 0.0% 233.7% 0.0%  
Employees  0 0 1 0 0  
Employee growth %  0.0% 0.0% 0.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 95 611 574  
Balance sheet change%  0.0% 0.0% 0.0% 540.5% -5.9%  
Added value  0.0 0.0 -91.7 605.7 -10.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 511 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 1.0 -1.0  

Profitability 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% -32.5% 64.4% 213.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -62.3% 159.8% -1.8%  
ROI %  0.0% 0.0% -66.4% 166.5% -1.8%  
ROE %  0.0% 0.0% -96.3% 187.2% -1.8%  

Solidity 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Equity ratio %  0.0% 0.0% -35.2% 95.8% 100.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -47.1% -8.4% 269.5%  
Gearing %  0.0% 0.0% -266.1% 0.8% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.2% 3.7% 0.1%  

Liquidity 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Quick Ratio  0.0 0.0 0.6 3.9 0.0  
Current Ratio  0.0 0.0 0.6 3.9 0.0  
Cash and cash equivalent  0.0 0.0 94.8 55.4 28.6  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -51.9 73.7 29.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -92 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -92 0 0  
EBIT / employee  0 0 -92 0 0  
Net earnings / employee  0 0 -92 0 0